newsfilter
← Latest News
GlobeNewswire·

Letter to Shareholders from CEO Dr. Ryan Saadi

WARREN, N.J., May 18, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN). Dear Shareholders, Since Tevogen's 2024 public listing, we have remained focused on building a